C83.73
Burkitt lymphoma, intra-abdominal lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Burkitt lymphoma is a fast-growing type of non-Hodgkin lymphoma that originates in lymphatic tissue. When it involves intra-abdominal lymph nodes, it can affect organs within the abdominal cavity. Recognized under the ICD-10 code C83.73, this condition requires prompt medical attention due to its aggressive nature. While it can occur at any age, it is most common in children and young adults. Early diagnosis and treatment are vital for improving outcomes and managing symptoms effectively.
Causes & Symptoms
Clinical Causes: Genetic mutations that cause abnormal cell growth Infection with the Epstein-Barr virus (EBV), especially in certain cases Immunodeficiency states, such as HIV/AIDS or inherited immune disorders Exposure to specific chemicals or radiation (less common)
Key Symptoms: Swelling or a noticeable lump in the abdomen Persistent abdominal pain or discomfort Bowel changes, including diarrhea or constipation Unexplained weight loss Fever and night sweats Fatigue and weakness Loss of appetite
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Imaging studies, such as CT scans or PET scans, help determine the extent of the disease within the abdomen. A biopsy of the affected lymph nodes or surrounding tissue is essential for confirming the diagnosis, where cells are examined under a microscope. Additional tests may include blood tests to assess overall health and organ function. The goal is to determine the stage and spread of the lymphoma to guide treatment planning.
Treatment Protocols: Treatment options often involve intensive chemotherapy tailored to the individual's health and disease stage. Due to the aggressive nature of Burkitt lymphoma, prompt initiation of therapy is critical. In some cases, targeted therapies or immunotherapy may be utilized. Supportive care to manage side effects and maintain nutritional status is also important. Radiation therapy is less commonly used but may be considered in certain scenarios. Ongoing follow-up is necessary to monitor for remission or response to treatment.
Clinical Advice & FAQs
Billing Guidance
Is C83.73 a billable ICD-10 code?
Yes, C83.73 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.73?
Clinical documentation must specify the nature of Burkitt lymphoma, intra-abdominal lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference